These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
306 related articles for article (PubMed ID: 25015035)
21. CIP2A mediates erlotinib-induced apoptosis in non-small cell lung cancer cells without EGFR mutation. Wang CY; Chao TT; Chang FY; Chen YL; Tsai YT; Lin HI; Huang YC; Shiau CW; Yu CJ; Chen KF Lung Cancer; 2014 Aug; 85(2):152-60. PubMed ID: 24954871 [TBL] [Abstract][Full Text] [Related]
22. Cancerous inhibitor of protein phosphatase 2A (CIP2A) protein is involved in centrosome separation through the regulation of NIMA (never in mitosis gene A)-related kinase 2 (NEK2) protein activity. Jeong AL; Lee S; Park JS; Han S; Jang CY; Lim JS; Lee MS; Yang Y J Biol Chem; 2014 Jan; 289(1):28-40. PubMed ID: 24214971 [TBL] [Abstract][Full Text] [Related]
23. Micropeptide CIP2A-BP encoded by LINC00665 inhibits triple-negative breast cancer progression. Guo B; Wu S; Zhu X; Zhang L; Deng J; Li F; Wang Y; Zhang S; Wu R; Lu J; Zhou Y EMBO J; 2020 Jan; 39(1):e102190. PubMed ID: 31755573 [TBL] [Abstract][Full Text] [Related]
24. Cucurbitacin B induces inhibitory effects via the CIP2A/PP2A/C-KIT signaling axis in t(8;21) acute myeloid leukemia. Ma W; Xiang Y; Yang R; Zhang T; Xu J; Wu Y; Liu X; Xiang K; Zhao H; Liu Y; Si Y J Pharmacol Sci; 2019 Apr; 139(4):304-310. PubMed ID: 30852180 [TBL] [Abstract][Full Text] [Related]
25. CIP2A down regulation enhances the sensitivity of pancreatic cancer cells to gemcitabine. Xu P; Yao J; He J; Zhao L; Wang X; Li Z; Qian J Oncotarget; 2016 Mar; 7(12):14831-40. PubMed ID: 26894380 [TBL] [Abstract][Full Text] [Related]
26. Chronic Cigarette Smoke Exposure Subdues PP2A Activity by Enhancing Expression of the Oncogene CIP2A. Nath S; Ohlmeyer M; Salathe MA; Poon J; Baumlin N; Foronjy RF; Geraghty P Am J Respir Cell Mol Biol; 2018 Dec; 59(6):695-705. PubMed ID: 30011381 [TBL] [Abstract][Full Text] [Related]
27. CIP2A overexpression is associated with c-Myc expression in colorectal cancer. Böckelman C; Koskensalo S; Hagström J; Lundin M; Ristimäki A; Haglund C Cancer Biol Ther; 2012 Mar; 13(5):289-95. PubMed ID: 22310977 [TBL] [Abstract][Full Text] [Related]
28. Oncoprotein CIP2A is stabilized via interaction with tumor suppressor PP2A/B56. Wang J; Okkeri J; Pavic K; Wang Z; Kauko O; Halonen T; Sarek G; Ojala PM; Rao Z; Xu W; Westermarck J EMBO Rep; 2017 Mar; 18(3):437-450. PubMed ID: 28174209 [TBL] [Abstract][Full Text] [Related]
29. Antihelminthic drug niclosamide inhibits CIP2A and reactivates tumor suppressor protein phosphatase 2A in non-small cell lung cancer cells. Kim MO; Choe MH; Yoon YN; Ahn J; Yoo M; Jung KY; An S; Hwang SG; Oh JS; Kim JS Biochem Pharmacol; 2017 Nov; 144():78-89. PubMed ID: 28813646 [TBL] [Abstract][Full Text] [Related]
30. Role of "oncogenic nexus" of CIP2A in breast oncogenesis: how does it work? De P; Carlson JH; Leyland-Jones B; Dey N Am J Cancer Res; 2015; 5(9):2872-91. PubMed ID: 26609493 [TBL] [Abstract][Full Text] [Related]
31. Tumor suppressor miR-375 regulates MYC expression via repression of CIP2A coding sequence through multiple miRNA-mRNA interactions. Jung HM; Patel RS; Phillips BL; Wang H; Cohen DM; Reinhold WC; Chang LJ; Yang LJ; Chan EK Mol Biol Cell; 2013 Jun; 24(11):1638-48, S1-7. PubMed ID: 23552692 [TBL] [Abstract][Full Text] [Related]
32. FL118 inhibits viability and induces apoptosis of colorectal cancer cells via inactivating the CIP2A/PP2A axis. Lin X; Gao M; Zhang A; Tong J; Zhang X; Su Q; Yang Z; Gao H; Jiang G Life Sci; 2019 Dec; 239():117074. PubMed ID: 31751585 [TBL] [Abstract][Full Text] [Related]
33. Euxanthone suppresses tumor growth and metastasis in colorectal cancer via targeting CIP2A/PP2A pathway. Wang N; Zhou F; Guo J; Zhu H; Luo S; Cao J Life Sci; 2018 Sep; 209():498-506. PubMed ID: 30144452 [TBL] [Abstract][Full Text] [Related]
34. Tamoxifen induces apoptosis through cancerous inhibitor of protein phosphatase 2A-dependent phospho-Akt inactivation in estrogen receptor-negative human breast cancer cells. Liu CY; Hung MH; Wang DS; Chu PY; Su JC; Teng TH; Huang CT; Chao TT; Wang CY; Shiau CW; Tseng LM; Chen KF Breast Cancer Res; 2014 Sep; 16(5):431. PubMed ID: 25228280 [TBL] [Abstract][Full Text] [Related]
35. CIP2A is a target of bortezomib in human triple negative breast cancer cells. Tseng LM; Liu CY; Chang KC; Chu PY; Shiau CW; Chen KF Breast Cancer Res; 2012 Apr; 14(2):R68. PubMed ID: 22537901 [TBL] [Abstract][Full Text] [Related]
36. Cancerous inhibitor of PP2A (CIP2A) at diagnosis of chronic myeloid leukemia is a critical determinant of disease progression. Lucas CM; Harris RJ; Giannoudis A; Copland M; Slupsky JR; Clark RE Blood; 2011 Jun; 117(24):6660-8. PubMed ID: 21490338 [TBL] [Abstract][Full Text] [Related]
37. CIP2A, an oncoprotein, is associated with cell proliferation, invasion and migration in laryngeal carcinoma cells. Chen XD; Tang SX; Zhang JH; Zhang LT; Wang YW Oncol Rep; 2017 Aug; 38(2):1005-1012. PubMed ID: 28656258 [TBL] [Abstract][Full Text] [Related]
38. Comparative analysis of a panel of biomarkers related to protein phosphatase 2A between laryngeal squamous cell carcinoma tissues and adjacent normal tissues. Wang HY; Yuan H; Liu JH; Wang BL; Xu KL; Huang P; Lin ZH; Xu LH J Zhejiang Univ Sci B; 2019 Sept.; 20(9):776-780. PubMed ID: 31379147 [TBL] [Abstract][Full Text] [Related]
39. Afatinib induces apoptosis in NSCLC without EGFR mutation through Elk-1-mediated suppression of CIP2A. Chao TT; Wang CY; Chen YL; Lai CC; Chang FY; Tsai YT; Chao CH; Shiau CW; Huang YC; Yu CJ; Chen KF Oncotarget; 2015 Feb; 6(4):2164-79. PubMed ID: 25537503 [TBL] [Abstract][Full Text] [Related]
40. Cancerous inhibitor of protein phosphatase 2A determines bortezomib-induced apoptosis in leukemia cells. Liu CY; Shiau CW; Kuo HY; Huang HP; Chen MH; Tzeng CH; Chen KF Haematologica; 2013 May; 98(5):729-38. PubMed ID: 22983581 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]